Drawing for SBL

USPTO serial 76423184

SBL

Reviewed by CopyMark Law Group

Reg. 2818880Status 710
Filing date
Status date
Registration date
Mar 2, 2004
Examiner
DALIER, JOHN DAVID
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SBL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

STEPHANIE K. WADE

STEPHANIE K WADE DICKSTEIN SHAPIRO1825 EYE ST NWWASHINGTON, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS FOR HUMAN AND VETERINARY USE FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR, DENTAL AND PERIODONTAL, DERMATOLOGIC, ENDOCRINE AND METABOLIC, GASTROINTESTINAL, GENETIC, HEMATOLOGIC, HEPATIC, IMMUNOLOGIC, LYMPHATIC, OSTEOLOGIC, NEUROLOGIC, OPHTHALMIC, PSYCHIATRIC, REPRODUCTIVE SYSTEM, RESPIRATORY TRACT, RENAL, AND URINARY TRACT DISEASES AND DISORDERS; PHARMACEUTICAL PREPARATIONS FOR HUMAN AND VETERINARY USE, NAMELY, ANALGESICS, ANESTHETICS, ANTIBIOTICS, ANTI-CANCER PREPARATIONS, ANTIHISTAMINES, ANTI-INFECTIVES, ANTI-INFLAMMATORIES, ANTI-MIGRAINES, ANTI-PARASITICS, ANTIVIRALS, INSULIN, HORMONES, HORMONE ANTAGONISTS, ENZYME INHIBITORS, STEROIDS, VACCINES; ADJUVANTS FOR VACCINES; DIAGNOSTIC PREPARATIONS FOR MEDICAL PURPOSESSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2010C8..CANCELLED SEC. 8 (6-YR)—
May 29, 2007CFITCASE FILE IN TICRS—
Nov 20, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 2, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 21, 2004IUCNNOTICE OF ALLOWANCE CANCELLED—
Oct 7, 20031.BDSec. 1(B) CLAIM DELETED—
Oct 7, 2003MAILPAPER RECEIVED—
Sep 23, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 1, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2003NPUBNOTICE OF PUBLICATION—
May 1, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2003MAILPAPER RECEIVED—
Sep 23, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance